drugset / Trial / NCT00141089
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
RandomizedParallel-groupDouble-blindTreatment
Summary
Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a class of subgroup-selective 5-hydroxytryptamine (5-HT) agonists. The aim of this study was to evaluate the efficacy and safety of tegaserod on bowel habits in male patients with chronic constipation.
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tegaserod | Small molecule | — | — |